NB

Neil Beeharry

AT Ai Therapeutics: 5 patents #6 of 12Top 50%
IR Institute For Cancer Research: 3 patents #7 of 104Top 7%
📍 Philadelphia, PA: #294 of 4,834 inventorsTop 7%
🗺 Pennsylvania: #7,358 of 74,527 inventorsTop 10%
Overall (All Time): #450,111 of 4,157,543Top 15%
11
Patents All Time

Issued Patents All Time

Showing 1–11 of 11 patents

Patent #TitleCo-InventorsDate
11266654 Apilimod compositions and methods for using same Henri Lichenstein, Jonathan M. Rothberg, Sophia Gayle, Paul Beckett, Sean Landrette +3 more 2022-03-08
11166944 Apilimod compositions and methods for using same in the treatment of renal cancer Sophia Gayle, Sean Landrette, Paul Beckett, Chris Conrad, Tian Xu +2 more 2021-11-09
10799508 Methods for treating cancer using HSP90 inhibitors Marylens Hernandez, Sean Landrette, Tian Xu, Jonathan M. Rothberg, Henri Lichenstein 2020-10-13
10765682 Apilimod for use in the treatment of melanoma Sophia Gayle, Sean Landrette, Paul Beckett, Chris Conrad, Tian Xu +2 more 2020-09-08
10729694 Anti-viral compositions containing PIKfyve inhibitors and use thereof Henri Lichenstein, Jonathan M. Rothberg, Paul Beckett, Sean Landrette, Chris Conrad 2020-08-04
10350213 Methods for treating cancer using apilimod Henri Lichenstein, Jonathan M. Rothberg, Sophia Gayle, Paul Beckett, Sean Landrette +2 more 2019-07-16
10220051 Combination of DNA repair inhibition with bendamustine or gemcitabine in the treatment of cancer Alfonso Bellacosa, Timothy J. Yen, Mitchell Smith, Rossella Tricarico, Vikram Bhattacharjee +1 more 2019-03-05
10206910 Apilimod for use in the treatment of renal cancer Sophia Gayle, Sean Landrette, Paul Beckett, Chris Conrad, Tian Xu +2 more 2019-02-19
10179135 Apilimod compositions and methods for using same Henri Lichenstein, Jonathan M. Rothberg, Sophia Gayle, Paul Beckett, Sean Landrette +3 more 2019-01-15
9421203 Sensitization of cancer cells to DNA damage by inhibiting kinases essential for DNA damage checkpoint control Timothy J. Yen 2016-08-23
8927516 Combination of DNA repair inhibition with bendamustine or gemcitabine in the treatment of cancer Alfonso Bellacosa, Timothy J. Yen, Mitchell Smith 2015-01-06